Simplex Trading’s AYTU BioPharma AYTU Stock Holding History

Simplex Trading’s Portfolio AYTU Stock Details AYTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5	Closed	–	–	8992
2022 Q4	$0	Sell	5 -205	-98%	-$772	﹤0.01%	9189
2022 Q3	$0	Sell	210 -25	-11%	-$190	﹤0.01%	9873
2022 Q2	$3K	Buy	+235	New	+$3.01K	﹤0.01%	9106
2021 Q4	–	Sell	-36	Closed	-$1.56K	–	10451
2021 Q3	$3K	Hold	36	–	–	﹤0.01%	9397
2021 Q2	$3K	Sell	36 -27	-43%	-$3.17K	﹤0.01%	9583
2021 Q1	$9K	Buy	+63	New	+$10K	﹤0.01%	7929

Other funds holding AYTU

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Simplex Trading's AYTU Position: Q1 2023 in Review

Simplex Trading sold out of AYTU BioPharma (AYTU) in Q1 2023, closing a stake of 5 shares.

Simplex Trading first reported a position in AYTU in Q1 2021 and held it in 6 quarters. The position peaked at $9K in Q1 2021. 21 funds tracked by Wall St. Rank hold AYTU as of Q1 2023.

Simplex Trading reported no remaining AYTU BioPharma position as of Q1 2023 after selling out during the quarter.
Simplex Trading sold 5 AYTU BioPharma shares in Q1 2023.
Simplex Trading first reported a position in AYTU BioPharma in Q1 2021 and held it in 6 quarters.
Simplex Trading's AYTU BioPharma position peaked at $9K in Q1 2021.
21 funds tracked by Wall St. Rank held AYTU BioPharma as of Q1 2023.

Based on Simplex Trading's 13F filing for Q1 2023, filed 27 Apr 2023.